Stay updated on AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial
Sign up to get notified when there's something new on the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page.

Latest updates to the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page
- ChecktodayChange DetectedThe page footer now displays Revision: v3.6.3 instead of Revision: v3.6.2, indicating a minor site version update.SummaryDifference0.0%

- Check7 days agoChange DetectedThe page’s revision identifier was updated from v3.6.0 to v3.6.2, indicating a small metadata update to the page’s version tag.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedAdded a recruitment-status note indicating enrollment has ceased, and introduced new help/navigation sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', along with a site revision tag 'Revision: v3.6.0'.SummaryDifference0.5%

- Check29 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, signaling a new version of the content.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, signaling a new version of the page content. This change represents a refresh of the page’s metadata and accompanying text for the study record.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page’s revision label was updated to v3.5.3, replacing v3.5.2, indicating an update to the page’s revision history rather than to study content.SummaryDifference0.0%

Stay in the know with updates to AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page.